Brainstorm Cell Therapeutics

Youtube Subscribe

Open: 2.87 Close: 2.76 Change: -0.11

How to get information about Brainstorm Cell Therapeutics Company Inc Stock without reading the whole internet.

How much time have you spent trying to decide whether investing in Brainstorm Cell Therapeutics? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Brainstorm Cell …

Concept Map

Semantic Network

Stock Summary

Brainstorm Cell Therapeutics Inc. engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. NurOwn is developing NurOwn, which has completed Phase III clinical trial for the.

Today's Summary

Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Rating ) last issued its quarterly earnings results on Thursday. The firm has a 50 day moving average of $2.41 and a two-hundred-day moving average.

Today's News

Shares of BCLI stock opened at $2.76 on Friday. Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Rating ) last issued its quarterly earnings results on Thursday. Brainstorm Cell Therapeutics stock last closed at $2.76, down 3.5% from the previous day, and has increased 1.85% in one year. The stock market analysis website can help you decide if BCLI is a good stock. Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Rating ) last released its quarterly earnings results on Thursday, March 30th. The firm has a 50 day moving average of $2.41 and a two-hundred-day moving average. The current price of Brainstorm cell is the price at which the company is currently trading.

Stock Profile

"Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York."

Keywords

Are looking for the most relevant information about Brainstorm Cell Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Brainstorm Cell Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Brainstorm Cell Therapeutics are: stock, Brainstorm, Cell, Therapeutics, last, BCLI, NASDAQBCLI, and the most common words in the summary are: cell, market, brainstorm, therapeutic, therapy, stem, stock, . One of the sentences in the summary was: Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Rating ) last issued its quarterly earnings results on Thursday. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #cell #market #brainstorm #therapeutic #therapy #stem #stock.

Read more →

Youtube Subscribe

---